Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2025 May 15;27(4):1017-1018.
doi: 10.1093/neuonc/noaf003.

Predicting recurrence of meningioma using DNA methylation for clinical practice

Karenna J Groff  1 , Matija Snuderl  1
Affiliations
Editorial

Predicting recurrence of meningioma using DNA methylation for clinical practice

Karenna J Groff et al. Neuro Oncol. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

M.S. is a scientific advisor and shareholder of Heidelberg Epignostix and Halo Dx, and a scientific advisor of Arima Genomics, and InnoSIGN, and received research funding from Lilly USA. Other authors declare no conflict of interest.

Comment on

  • Validation and next-generation update of a DNA methylation-based recurrence predictor for meningioma: A multicenter prospective study.
    Landry AP, Wang JZ, Patil V, Gui C, Mamatjan Y, Patel Z, Yakubov R, Kaloti R, Habibi P, Wilson M, Ajisebutu A, Ellenbogen Y, Wei Q, Singh O, Sosa J, Mansouri S, Wilson C, Cohen-Gadol AA, Virtanen P, Burket N, Blackwell M, Koenig J, Alfonso A, Davis J, Zaazoue MA, Tabatabai G, Tatagiba M, Behling F, Barnholtz-Sloan JS, Sloan AE, Chotai S, Chambless LB, Mansouri A, Ehret F, Capper D, Tsang DS, Aldape K, Gao A; International Consortium on Meningiomas (ICOM); Nassiri F, Zadeh G. Landry AP, et al. Neuro Oncol. 2025 May 15;27(4):1004-1016. doi: 10.1093/neuonc/noae236. Neuro Oncol. 2025. PMID: 39503370 Free PMC article.

References

    1. Capper D, Jones DTW, Sill M, et al. DNA methylation-based classification of central nervous system tumours. Nature. 2018;555(7697):469–474. - PMC - PubMed
    1. Galbraith K, Vasudevaraja V, Serrano J, et al. Clinical utility of whole-genome DNA methylation profiling as a primary molecular diagnostic assay for central nervous system tumors-A prospective study and guidelines for clinical testing. Neurooncol. Adv. 2023;5(1):vdad076. - PMC - PubMed
    1. Hovestadt V, Remke M, Kool M, et al. Robust molecular subgrouping and copy-number profiling of medulloblastoma from small amounts of archival tumour material using high-density DNA methylation arrays. Acta Neuropathol. 2013;125(6):913–916. - PMC - PubMed
    1. Simon M, Gousias K. Grading meningioma resections: the Simpson classification and beyond. Acta Neurochir (Wien). 2024;166(1):28. - PMC - PubMed
    1. Sahm F, Schrimpf D, Stichel D, et al. DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis. Lancet Oncol. 2017;18(5):682–694. - PubMed

LinkOut - more resources